KRAS G12C mutations are found in about 12-13% of LUAD samples and it is unclear whether they are associated with worse survival outcomes in resected, stage I LUAD. We assessed whether KRAS-G12C mutated tumours had worse DFS when compared to KRAS-nonG12C mutated tumours and to KRAS wild-type tumours in a cohort of resected, stage I LUAD (IRE cohort). We then leveraged on publicly available datasets (TCGA-LUAD, MSK-LUAD604) to further test the hypothesis in external cohorts. In the stage I IRE cohort we found a significant association between the KRAS-G12C mutation and worse DFS in multivariable analysis (HR: 2.47). In the TCGA-LUAD stage I cohort we did not find statistically significant associations between the KRAS-G12C mutation and DFS. In the MSK-LUAD604 stage I cohort we found that KRAS-G12C mutated tumours had worse RFS when compared to KRAS-nonG12C mutated tumours in univariable analysis (HR 3.5). In the pooled stage I cohort we found that KRAS-G12C mutated tumours had worse DFS when compared to KRAS-nonG12C mutated tumours (HR 2.6), to KRAS wild-type tumours (HR 1.6) and to any other tumours (HR 1.8); in multivariable analysis, the KRAS-G12C mutation was associated with worse DFS (HR 1.61). Our results suggest that patients with resected, stage I LUAD with a KRAS-G12C mutation may have inferior survival outcomes..

KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma / Gallina, F T; Marinelli, D; Melis, E; Forcella, D; Taje, R; Buglioni, S; Visca, P; Torchia, A; Cecere, F L; Botticelli, A; Santini, D; Ciliberto, G; Cappuzzo, F; Facciolo, F. - In: LUNG CANCER. - ISSN 0169-5002. - 181:(2023). [10.1016/j.lungcan.2023.107254]

KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma

Gallina, F T
Co-primo
;
Marinelli, D
Co-primo
;
Torchia, A;Botticelli, A;Santini, D;
2023

Abstract

KRAS G12C mutations are found in about 12-13% of LUAD samples and it is unclear whether they are associated with worse survival outcomes in resected, stage I LUAD. We assessed whether KRAS-G12C mutated tumours had worse DFS when compared to KRAS-nonG12C mutated tumours and to KRAS wild-type tumours in a cohort of resected, stage I LUAD (IRE cohort). We then leveraged on publicly available datasets (TCGA-LUAD, MSK-LUAD604) to further test the hypothesis in external cohorts. In the stage I IRE cohort we found a significant association between the KRAS-G12C mutation and worse DFS in multivariable analysis (HR: 2.47). In the TCGA-LUAD stage I cohort we did not find statistically significant associations between the KRAS-G12C mutation and DFS. In the MSK-LUAD604 stage I cohort we found that KRAS-G12C mutated tumours had worse RFS when compared to KRAS-nonG12C mutated tumours in univariable analysis (HR 3.5). In the pooled stage I cohort we found that KRAS-G12C mutated tumours had worse DFS when compared to KRAS-nonG12C mutated tumours (HR 2.6), to KRAS wild-type tumours (HR 1.6) and to any other tumours (HR 1.8); in multivariable analysis, the KRAS-G12C mutation was associated with worse DFS (HR 1.61). Our results suggest that patients with resected, stage I LUAD with a KRAS-G12C mutation may have inferior survival outcomes..
2023
early stage LUAD; KRAS mutations; lymphadenectomy; NGS
01 Pubblicazione su rivista::01a Articolo in rivista
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma / Gallina, F T; Marinelli, D; Melis, E; Forcella, D; Taje, R; Buglioni, S; Visca, P; Torchia, A; Cecere, F L; Botticelli, A; Santini, D; Ciliberto, G; Cappuzzo, F; Facciolo, F. - In: LUNG CANCER. - ISSN 0169-5002. - 181:(2023). [10.1016/j.lungcan.2023.107254]
File allegati a questo prodotto
File Dimensione Formato  
Gallina_KRAS G12C_2023.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 4.05 MB
Formato Adobe PDF
4.05 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1682045
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact